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Introduction. This paper compares diﬀerent approaches to recanalization in a model of the middle cerebral artery (MCA).
Methods. An occlusive thrombus (lamb’s blood) was introduced into the MCA of a model of the cerebral circulation perfused
with Hartmann’s solution (80 pulsations/min, mean pressure 90mmHg). Three methods of clot retrieval were tested: thrombus
aspiration via a 4F catheter (n = 26), thrombus aspiration via the GP thrombus aspiration device (GPTAD) (n = 30), and
mechanical thrombectomy via the Solitaire Device (n = 30). Results. Recanalization rate was similar for all 3 approaches (62%,
77%, and 85%). Time to recanalization was faster with aspiration devices (41 SD 42s for 4F and 61 SD 21s for GPTAD) than with
the Solitaire (197 SD 64s P<. 05 Kruksal-Wallis). Clot fragmentation was the same in the Solitaire (23%) and the GPTAD (23%),
but higher with the 4F (53%, P<. 05). Conclusion. In this model, thrombus aspiration was faster than mechanical thrombectomy,
and similarly eﬀective at recanalization. These results should be conﬁrmed in vivo.
1.Introduction
The aim of treatment of an acute ischaemic stroke is to
recanalize the occluded cerebral artery to restore cerebral
perfusion. This limits the damage to the cerebral tissue,
reduces infarct size, and therefore improves long-term
outcome [1]. There is no sparing of cerebral tissue damage
beyond 6-7 hours or longer after onset [2].
Intravenous thrombolysis using recombinant tissue plas-
minogen activator (rt-PA) within 4.5 hours of onset of
symptoms of acute stroke has been shown to improve out-
come signiﬁcantly [3]. Recanalization rates vary from 30
to 92% during the ﬁrst 6–24 hours after treatment with
intravenous thrombolysis [1]. However, there are drawbacks
to using thrombolysis, such as the short time window for
treatment and the risk of intracerebral (ICH) and systemic
haemorrhage. This has limited the number of stroke patients
receiving thrombolysis to an estimated 4% in Europe [3].
Thrombectomy involves the recanalization of an artery
via endovascular extraction of the thrombus through a
catheter using a mechanical thrombectomy device (MTD)
[4]. This is an alternative approach to clot removal and may2 Stroke Research and Treatment
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Figure 1:Diagramofthepulsatileﬂowsystem.Bluearrowsindicate
direction of perfusate ﬂow.
overcome some of the problems above [5]. Thrombectomy
is considered if patients present beyond the approved treat-
ment window for intravenous thrombolysis, if they fail to
recanalizeafterIVthrombolysis,oriftheyhavecontraindica-
tionstothrombolysis.Thetimelimitforthrombectomyafter
middle cerebral artery (MCA) occlusion is 6–8 hours after
symptom onset [1], thus providing a signiﬁcantly longer
intervention opportunity.
Problems with thrombectomy include the need for
sedation/anaesthesia, the time taken to organize and per-
form the procedure, diﬃculties in navigation of the device
intracranially, and in capture of the thrombi within the
tortuous carotid arteries and intracranial vessels. Further-
more, devices may fracture leaving it diﬃcult to retrieve
components and there is a risk of damage to the artery
wall, causing haemorrhage or vasospasm and a risk of distal
embolization due to clot fragmentation, causing further
ischaemia [2, 6, 7].
The GP thrombus aspiration device (GPTAD) [8]m a y
overcome some of the problems associated with mechanical
thrombectomy.Ithasnomovingparts,thusreducingtherisk
of device fracture. It does not enter or disrupt the clot and
allows aspiration during clot retrieval, reducing the risk of
loose fragments. The vortex pattern ﬂow generated by the
GPTAD during suction is associated with low forces at the
periphery of the device reducing the risk of arterial collapse
[9–11]. An earlier study [12] demonstrated (i) that the
GPTAD (previously called the GP MTD) can be eﬀectively
maneuvered though a model of the larger intracerebral
arteries, (ii) that there is a correlation between the pressure
required for extraction and the mass of the thrombus,
(iii) that thrombus removal via the GPTAD can be further
enhanced by the addition of alteplase to the perfusate, and
(iv) that the use of the GPTAD does not damage the arterial
wall of abattoir porcine artery walls studied in-vitro with
suction pressures of up to 30KPa. These experiments have
Figure 2: Prepared clot.
shown that thrombus aspiration via the GPTAD is feasible
and more eﬀective than aspiration through a simple catheter
in vitro.
The aim of this study is to compare the eﬀectiveness of
thrombus aspiration using the GPTAD and a simple catheter
with mechanical thrombectomy using the Solitaire Device, a
retrievable, detachable stent-platform-based thrombectomy
device already in clinical use within Europe [13, 14].
2. Methods
Three methods of recanalization of an occluded vessel were
tested in a pulsatile model of the cerebral circulation.
2.1. The Pulsatile Flow System. The experimental pulsatile
ﬂow system used to simulate the cerebral circulation
(Figure 1) has been previously described [15]. It was per-
fused with Hartmann’s solution (Baxter Healthcare Ltd.,
Thetford,N orfolk,UK)andplacedinabeakerinawaterbath
(Grant Instruments Cambridge, UK) at 37◦C. A peristaltic
pump (Watson Marlow, Falmouth, Cornwall, UK) was used
to create a pulsatile ﬂow of 80 pulsations per minute. A
silicone model of the middle cerebral artery (MCA) with an
internal diameter of 3mm (ELSTRAT Geneva, Switzerland)
was integrated into the ﬂow system. The perfusion pressure
was set to match a mean arterial pressure (MAP) of
90mmHg using a hydrostatic pressure adjustment. To do
this,asecondcirculationinparalleltotheexistingcirculation
with the MCA was set up with an outﬂow 122cm (122cm
H2O/1.36mmHg = 90mmHg) above the MCA.
2.2.ThrombusPreparationandLoadingintothePulsatileFlow
System. Lambs’ blood (AJ Greens Abattoir, Stoke, UK) was
allowed to coagulate for 24h, shaped using a scalpel into
clots of an approximately 5mm diameter and 30mm length
(Figure 2), washed in Hartmann’s solution, and drip dried.
Clot weight was recorded using electronic scales (Ohaus,
Pinebrook, USA) before and after introduction into the
experimental vascular system.
The clot was placed in the reservoir of Hartmann’s
solution, with the peristaltic pump turned oﬀ.T h ep u m p
was then turned on with ﬂow in the reverse direction toStroke Research and Treatment 3
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Figure 4: Devices used for clot aspiration: the 4F catheter (top) and
the GPTAD (below).
physiological ﬂow allowing the thrombus to travel along the
collateral vessel past the model MCA. The pump was then
turned oﬀ, and the collateral vessel was occluded using a
clamp.Thepumpwasturnedbackonwithﬂowinthecorrect
physiological direction causing the thrombus to enter and
occlude the model MCA. The ﬁnal thrombus length was
then measured in situ using a ruler (Figure 3). The peristaltic
pump was turned on (80bpm), and the collateral vessel
opened to resume ﬂow [15].
2.3. Devices and Techniques Used for Recanalization. Devices
used for thrombus aspiration are shown in Figure 4.
The Gwen Pearce thrombus aspiration device (GPTAD)
(Pearce G, Perkinson N, inventors; US patent application
0509583.1.2005) is an embedded thrombectomy device of
1mm diameter within a 4F catheter, with a helical engraving
on its internal surface (KIMAL, Uxbridge, UK). The GPTAD
was introduced into the silicone tubing leading to the model
MCA through a shortened (20cm) 6F catheter, which was
used as a sheath (10cm inside and 10 cm outside the entry
point into the model vascular system) and advanced towards
the clot. When the catheter tip was within 3–5mm of the
proximal aspect of the clot, the suction pump, set at 50kPa,
was turned on. The thrombus was then aspirated into the
device tip and removed from the model MCA attached to
the catheter tip. This was done in a controlled way under
constant traction to avoid loss of contact with the clot during
(a)
(b)
Figure 5: Solitaire AB Device expanded (a) and after clot retrieval
(b).
extraction.Afterremovalofthe4Fcatheter,thesheathstayed
in place for subsequent experiments. A 4F catheter (4F)
attached to a suction pump was used as a control. This was
inserted through the 6F sheath, advanced towards the clot,
and withdrawn in the same way as described for the GPTAD.
The same suction pressure of 50kPa was applied to aspirate
the clot.
Mechanical thrombectomy was performed using the
SolitaireABDevice(Figure 5(a)),aselfexpandingretrievable
stent (ev3 Inc., Irvine, California), using techniques shown
in the Solitaire operating guideline [16]. An 8F catheter, con-
nected to a rheostatic valve, was introduced into the silicone
tube leading to the model MCA. Through this, a 0.014-inch
guide wire (Boston Scientiﬁc, FA, USA) was threaded and
advanced to pass between the vessel wall and thrombus, to
a ﬁnal position just beyond the thrombus. A microcatheter
(0.021  )c o n n e c t e dt oar h e o s t a t i cv a l v ew a sg u i d e db e y o n d
the thrombus using the microguidewire. The Solitaire was
fed down the microcatheter, and the stent (4 × 20mm)
was deployed through the thrombus by pulling back on the
microcatheter. The device was withdrawn slowly with the
microcatheter and thrombus and removed from the model
MCA. Figure 5(b) shows a clot within the stent framework.
After each experiment, the catheters and devices were
ﬂushed with Hartmann’s solution to remove any remaining
lumenobstructionand air locks. Fiveattempts toretrieve the
clot were allowed. If these were unsuccessful, the results were
recorded as a fail. All experiments were performed by the
same researcher.
2.4. Assessments. Recanalization was assessed visually and
deﬁned as complete removal of the thrombus with unob-
structed free ﬂow of Hartmann’s solution through the previ-
ously occluded vessel. It was scored as 1 (successful complete
removal) or 0 (unsuccessful or incomplete removal).
Clot fragmentation was assessed by inspection of the clot
after retrieval and scored as 1 (more than one fragment) or 0
(no fragmentation/clot removed in one piece).4 Stroke Research and Treatment
Table 1: Summary of results for each device.
Device 4F catheter GPTAD Solitaire P-value
Number of experiments (n)2 6 3 0 2 6 —
Recanalization (n, (%)) 16 (62%) 23 (77%) 22 (85%) Ns∗
Fragmentation (n, (%)) 14 (53%) 7 (23%) 6 (23%) <.05∗
Number of attempts at retrieval (mean, (SD)) 1.9 (1.0) 2.3 (1.4) 1.3 (0.5) Ns∗∗
Time to successful recanalization (mean, SD) (s) 41 SD 42 (n = 16) 61 SD 21 (n = 23) 197 SD 64 (n = 22) <.05∗∗
∗C h i - s q u a r e dt e s t( 2×3t a b l e ) ,∗∗Kruksal-Wallis test, n: number, SD: standard deviation.
T h et i m er e q u i r e df o rc o m p l e t ec l o tremoval was recorded.
This was measured using a stopwatch from deployment
of each device into the system to complete removal of
the thrombus from the model MCA. The duration of the
experiment was measured from deployment of the device
to successful removal or to the end of the ﬁfth attempt of
removal (if removal was unsuccessful). Interaction between
the thrombus and the thrombectomy device was assessed by
visual inspection.
2.5. Statistical Methods. Descriptive statistics and counts
were performed using Microsoft Excel (Microsoft Oﬃce
XP, Microsoft Corporation, US) and tests of signiﬁcance
(as detailed in the text) were carried out using Minitab
15 (Minitab Inc., USA, http://www.minitab.com/) statistical
software package.
3. Results
Eighty-two experiments were performed in total, and the
results of the experiments are summarised in Table 1.
3.1. Clot Length before Extraction. The length of the clots
occluding the MCA was 16–68mm for the 4F, 21–55mm for
the GPTAD, and 20–45mm for the Solitaire.
3.2. Recanalization. There was no signiﬁcant diﬀerence in
the rate of recanalization between the three devices (16/26
(62%) for the 4F, 23/30 (77%) for the GPTAD, and 22/26
(85%) for the Solitaire, P = .2, 2 × 3 2-tailed Chi-squared
test). Individual 2 × 2 comparisons (2-tailed Fisher’s exact
test) between devices also show no signiﬁcant diﬀerences (4F
versus GPTAD P = .3,4FversusSolitaireP = .1,andGPTAD
versus Solitaire P = .5).
3.3.ClotFragmentation. Thereweresigniﬁcantdiﬀerencesin
theincidenceofclotfragmentationbetweenthethreedevices
with rates of 14/26 (53%) for the 4F, 7/30 (23%) for the
GPTAD, and 6/26 (23%) for the Solitaire (P = .02, 2 × 3
2-tailed Chi-squared test). Individual comparisons (2-tailed
Fisher’s exact tests) between devices show signiﬁcantly more
fragmentation with the 4F than with the GPTAD (P = .04)
and the Solitaire (P = .03) but no diﬀerence between the
GPTAD and the Solitaire (P = 1.0).
3.4. Time Taken for Successful Recanalization. The mean time
taken for successful recanalization was 41 SD 42s (n = 16)
for the 4F, 61 SD 21s (n = 23) for the GPTAD, and 197
SD 64s (n = 22) for the Solitaire (P<. 05, Kruksal-Wallis).
Individual comparisons between the 3 devices showed that
the mean time taken to remove the clot was signiﬁcantly
longer with the Solitaire than with two aspiration devices
(P<. 05 Kruksal-Wallis one-way analysis of variance). There
was no signiﬁcant diﬀerence in the time taken for successful
clot removal between the 4F and the GPTAD.
3.5. Device-Clot Interaction. Device-clot interaction was
determinedbyvisualinspectionandbysubjectiveassessment
of the procedure by the researcher conducting the experi-
ment. With the distal device (Solitaire), the passage of the
microguidewire and microcatheter past the thrombus was
simple. The Solitaire device deployed into the thrombus and
grasped it well within the struts (Figure 5(b)). It was also
able to catch a fragmented clot if it embolized distally by
pushing the device further down the tubing. Withdrawal
had to be controlled done very slowly and, otherwise the
thrombus was lost. The aspiration devices stretched the
thrombus during the aspiration process. The thrombus
engaged in the tip of the catheter and was either pulled out
whole or it broke up, leaving one or more fragments in
the model circulation. The GPTAD appeared to grasp the
clot eﬀectively, and the removal was simple and smooth.
However, if the clot fragmented, the device would sometimes
b eb l o c k e da n dw o u l dh a v et ob ec l e a r e d .T h i sw a sd o n e
by removing the device from the system and ﬂushing it.
The 4F catheter was eﬀective for thrombus removal but
often caused clot fragmentation immediately on interacting
with the thrombus. When it removed the thrombus, it was
eﬀective and smooth, but sometimes interaction with the
thrombus was lost.
3.6. Complications. There were no complications with the
Solitaireor4Fdevices.TheGPTADhadtobepassedcarefully
so that the plastic sheath around the tip did not collapse,
which did occur but could be corrected.
4. Discussion
The main ﬁndings of the study are that all three devices suc-
cessfullyremovedthemajorityofclotsfromthemodelMCA.
There was no signiﬁcant diﬀerence in overall recanalization
rates between the three devices. The 4F catheter was most
likely to fragment the clot. Time to complete clot removalStroke Research and Treatment 5
wasfasterwithaspirationdevices(4FandGPTAD)thanwith
the Solitaire.
4.1. Recanalization. A meta-analysis of 53 studies involving
2066 patients has shown that recanalization is strongly asso-
ciated with improved functional outcomes and improved
mortality [17]. Our data show that there was no signiﬁcant
diﬀerence in the eﬀectiveness of the three tested devices
in achieving recanalization in this model. Recanalization
rates were 15% higher with the GPTAD than with the 4F
and a further 8% higher with the Solitaire than with the
GPTAD. Such small diﬀerences would require a much larger
numberofexperimentstoidentifyanystatisticalsigniﬁcance.
Successful thromboaspiration using catheters of varying
calibre (4–8F) has been reported in vivo [4, 18–22]. In this
study, clot aspiration via the GPTAD was nonsigniﬁcantly
more eﬀective than via the 4F catheter alone. This may be
due to the creation of the vortex at the tip of the GPTAD,
allowing for more controlled clot capture. There was also
a trend towards higher removal rates with the Solitaire
than with either aspiration device. It has previously been
shown in animal studies that recanalization is better using
distal devices compared to proximal devices [6]. Even higher
recanalization rates of 90–100% have been achieved with the
Solitaire Device in combination with thrombolysis in human
case series [13, 14].
4.2. Fragmentation. This study showed signiﬁcantly more
clot fragmentation with two aspiration devices than with
the Solitaire. However, only clots removed via the aspi-
ration/thrombectomy devices were counted. Assessment,
therefore, included thrombi which were removed in several
segments but had no potential for distal embolization
because the segments were aspirated before the ﬁnal occlu-
sive fraction of the clot has been removed, thus not leading
to distal embolization. The clinical relevance of the clot
fragmentation described here is, therefore, unclear.
4.3. Time Taken for Successful Recanalization. T h et i m et a k e n
for successful recanalization was signiﬁcantly less with the
aspiration devices than with the Solitaire. Distal devices are
more complex mechanically than proximal devices and take
more time to deploy [6], hence, the longer time for the
Solitaire device compared to the GPTAD and 4F catheter.
Time to clot capture in this in vitro m o d e li sc o n s i d e r a b l y
faster than in vivo, since the vessel approach length is much
shorter, more easily visible, and less tortuous compared to
the human vascular system, and this would aﬀect the level
of time diﬀerences between devices in vivo. However, while
ourexperimentscannotbedirectlyextrapolatedtotheinvivo
state, the diﬀerences are due to the technique of deployment
and are likely to be observable in a greater or lesser extent
in vivo. The relative importance would be expected to be
less with a more complex and prolonged approach time to
the site of the thrombus. However, the disadvantage of the
longer recanalization time for the Solitaire in this model has
to be balanced against less clot fragmentation, which would
be relevant in vivo.
4.4. Clot-Device Interaction. In this study, the GPTAD
appeared to grasp the clot better than the 4F catheter,
with more successful ﬁrst-attempt removals, and this may
have caused less fragmentation. However, once the clot was
grasped, clot removal was smooth. Both devices appeared
to stretch the clot on removal. This has been shown to
reduce vasospasm on studies in animals [6]. The GPTAD
creates a vortex with suction and does not touch the clot
during removal [7], thus reducing the risk of fragmentation
compared to the 4F catheter. The Solitaire device uses
an open-slit, closed cell design which interacts with the
thrombus, giving an optimal radial force, increasing the
chance of clot trapping [19]. In this study, it ensnared clots
up to 45mm of length within the struts of the device. If the
clot was partially stretched, it would ensnare further down
the device.
4.5. Experiment Limitations. This is an experimental study
and, therefore, does not reﬂect the physiological environ-
ment in vivo with regard to forces involved between the
thrombus, the vessel wall, and devices and also vessel
d a m a g e ,p e r f o r a t i o n ,a n dv a s o s p a s m[ 23]. Clot adherence to
vessel walls cannot be replicated [12], and the Hartmann’s
solution used has diﬀerent characteristics from blood,
which may thrombolyse or form additional thrombi during
thrombectomy[24].Thesefactorsmayfurtheraﬀectrecanal-
ization. The model MCA was straight, and the navigation of
the sharp bends in the carotid artery was not reﬂected in the
silicone tubing. The device diameters diﬀered between the
suction catheters and the Solitaire, which may have aﬀected
results. The clots could also not be fully standardised, as
some fragmented more than others. Furthermore, optimal
placement of the device was ensured by direct visualization.
This cannot be done clinically, which may have increased the
recanalization rate for the devices.
5. Conclusion
In this experimental setup, thromboaspiration was as eﬀec-
tive as thrombectomy but faster. These experiments have
been performed in a model of the cerebral circulation and
should be conﬁrmed using in vivo studies. A combination
of proximal and distal approaches might increase speed and
recanalization rate.
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